Daily Stock Analysis, DVA, Davita Inc, priceseries

Davita Inc. Daily Stock Analysis
Stock Information
Open
110.05
Close
109.47
High
111.12
Low
109.09
Previous Close
110.06
Daily Price Gain
-0.59
YTD High
120.32
YTD High Date
Feb 16, 2022
YTD Low
105.48
YTD Low Date
Jan 31, 2022
YTD Price Change
-5.96
YTD Gain
-5.16%
52 Week High
136.48
52 Week High Date
Aug 4, 2021
52 Week Low
94.38
52 Week Low Date
Nov 30, 2021
52 Week Price Change
1.86
52 Week Gain
1.73%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Nov 24. 2017
57.15
Jan 30. 2018
78.04
44 Trading Days
36.56%
Link
LONG
Jun 17. 2019
49.25
Jul 8. 2019
55.74
14 Trading Days
13.17%
Link
LONG
Aug 30. 2019
56.37
Sep 19. 2019
60.03
13 Trading Days
6.50%
Link
LONG
Nov 1. 2019
59.54
Nov 29. 2019
71.82
19 Trading Days
20.62%
Link
LONG
Jan 10. 2020
75.95
Jan 31. 2020
80.80
14 Trading Days
6.39%
Link
LONG
Jul 14. 2020
81.95
Jul 31. 2020
87.06
13 Trading Days
6.24%
Link
LONG
Nov 2. 2020
89.07
Dec 1. 2020
108.99
20 Trading Days
22.36%
Link
LONG
Apr 15. 2021
109.85
May 18. 2021
122.48
23 Trading Days
11.50%
Link
LONG
Aug 2. 2021
121.37
Aug 25. 2021
130.34
17 Trading Days
7.39%
Link
LONG
Dec 6. 2021
102.10
Jan 6. 2022
111.76
22 Trading Days
9.47%
Link
Company Information
Stock Symbol
DVA
Exchange
NYSE
Company URL
http://www.davita.com
Company Phone
310-536-2668
CEO
Kent J. Thiry
Headquarters
Colorado
Business Address
2000 16TH STREET, DENVER, CO 80202
Sector
Equity
Industry Category
Health Services
Industry Group
Specialized Health Services
CIK
0000927066
About

DaVita, Inc. engages in the provision of medical care services. It operates through Kidney Care and HealthCare Partners segments. The Kidney Care segment focuses on the delivery of dialysis services to patients with chronic kidney failure and end stage renal disease. The HealthCare Partners segment deals with the management and operation of medical groups and affiliated physician networks in California, Nevada, New Mexico, Florida, Colorado, and Washington. The company was founded in 1994 and is headquartered in Denver, CO.

Description

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). It operates through two divisions, DaVita Kidney Care and DaVita Medical Group. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers, as well as patient and physician focused integrated health care delivery and management services. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2016, it provided dialysis and administrative services in the United States through a network of 2,350 outpatient dialysis centers serving approximately 187,700 patients; and operated 154 outpatient dialysis centers located in 11 countries outside of the United States. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.